Biohaven Pharmaceuticals Inc., of New Haven, Conn. recalls
1 recall recorded since 2018, most recently on 16 March 2023. Status and classification are as published by the CPSC.
Recalls1
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 16 March 2023
- Reason
- The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- Remedy
- Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.
- Recall number
- 23154
- Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.